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Introduction
Of the estimated 10.4 million people worldwide who devel-
oped tuberculosis in 2016, one third of these were undetected 
or unreported.1 In many so-called high-burden countries,2 
such as in the Democratic Republic of the Congo, the num-
ber of undetected cases exceeds 50%. With a tuberculosis 
incidence of 323 cases per year per 100 000 inhabitants1 
and an estimated population of 77 million inhabitants, over 
125 000 new cases of tuberculosis in the country go unde-
tected every year.
Previous evaluations of active case-finding interventions 
have failed to demonstrate their utility and sustainability in 
programmatic conditions, especially in reaching high-risk 
groups.3,4 However, a review by the World Health Organiza-
tion (WHO)5 and a later study6 revealed that, where baseline 
tuberculosis risks are high, the impact and cost–effectiveness 
of active case-finding on tuberculosis detection can also 
be high. Active case-finding is recommended by WHO for 
high-risk groups, defined as having: (i) a higher tuberculosis 
burden than the general population; (ii) limited access to 
health care; or (iii) a tuberculosis incidence of over 1000 per 
100 000 inhabitants per year.5
Active case-finding usually involves screening by trained 
health professionals. Such screeners can however be geograph-
ically and socially distant from populations at high risk for the 
disease screened. To address this issue, peer-led interventions 
have been piloted and have shown a positive impact on the 
control of diseases such as human immunodeficiency virus 
(HIV),7,8 malaria9 and tuberculosis.10,11
This study presents an intervention where we trained 
people who had been directly affected by tuberculosis, either 
those who had received treatment for tuberculosis or with a 
family history of tuberculosis, to conduct active case-finding. 
We expected that many of these people would already belong 
to the social groups and geographical areas of high risk of 
tuberculosis, which would facilitate access to these groups. 
Furthermore, we anticipated that having volunteer screeners 
who had themselves received tuberculosis treatment would 
increase empathy, decrease stigmatization and increase the 
acceptability of screening and tuberculosis testing.
The aims of the study were to investigate the effect of using 
such volunteer screeners, who would ask people considered to 
be at high risk of tuberculosis infection about the presence of 
a prolonged cough (lasting more than 15 days), and encourage 
attendance at a clinic for testing if they reported this symptom.
Objective To investigate the effect of using volunteer screeners in active tuberculosis case-finding in South Kivu, the Democratic Republic 
of the Congo, especially among groups at high risk of tuberculosis infection.
Methods To identify and screen high-risk groups in remote communities, we trained volunteer screeners, mainly those who had themselves 
received treatment for tuberculosis or had a family history of the disease. A non-profit organization was created and screeners received 
training on the disease and its transmission at 3-day workshops. Screeners recorded the number of people screened, reporting a prolonged 
cough and who attended a clinic for testing, as well as test results. Data were evaluated every quarter during the 3-year period of the 
intervention (2014–2016).
Findings Acceptability of the intervention was high. Volunteers screened 650 434 individuals in their communities, 73 418 of whom reported 
a prolonged cough; 50 368 subsequently attended a clinic for tuberculosis testing. Tuberculosis was diagnosed in 1 in 151 people screened, 
costing 0.29 United States dollars (US$) per person screened and US$ 44 per person diagnosed. Although members of high-risk groups with 
poorer access to health care represented only 5.1% (33 002/650 434) of those screened, they contributed 19.7% (845/4300) of tuberculosis 
diagnoses (1 diagnosis per 39 screened). The intervention resulted in an additional 4300 sputum-smear-positive pulmonary tuberculosis 
diagnoses, 42% (4 300/10 247) of the provincial total for that period.
Conclusion Patient-led active tuberculosis case-finding represents a valuable complement to traditional case-finding, and should be used 
to assist health systems in the elimination of tuberculosis.
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Methods
Setting
This study took place in the South Kivu 
province at the eastern border of the 
Democratic Republic of the Congo. 
Over two decades of conflicts have 
profoundly affected the inhabitants 
of the country,12,13 resulting in a size-
able military population. Further, the 
exploitation of gold-mining resources 
by the so-called artisanal mining sector 
means that thousands live in remote 
camps with adverse sanitary conditions 
and little access to health care.14 As well 
as people who live in the same house as 
others being treated for tuberculosis, 
the main tuberculosis high-risk envi-
ronments include prisons,15,16 mining 
communities17 and military camps.18,19
The estimated population of the 
province in 2015 was 5.8 million inhab-
itants,20 spread over 34 zones containing 
over 500 health facilities; only 113 of 
these health facilities provide tubercu-
losis services (an increase from just 78 
until 2014). Ziehl–Neelsen microscopy 
and first-line anti-tuberculosis drugs are 
provided free, but patients have to pay for 
initial medical visits. Ten clinics perform 
Xpert® MTB/RIF testing, a nucleic acid 
amplification test to detect Mycobac-
terium tuberculosis nucleic acid and a 
genetic sequence indicative of rifampicin 
resistance. This test is primarily used for 
retreatment patients and those infected 
with HIV. Tuberculosis diagnosis rarely 
involves chest radiographs as they are 
only available in a few clinics and cost 
patients 20 United States dollars (US$).
Intervention
The intervention programme began at 
the end of 2013 and we evaluated results 
every quarter until the end of 2016.
In 2013, cured patients living in 
the clinic catchment area were person-
ally contacted and invited to join an 
information session calling for volunteer 
screeners. Patients accepting the invita-
tion to become volunteers joined a local 
screening group, part of a provincial 
non-profit organization called Ambas-
sadeurs de Lutte Contre la Tuberculose. 
Funded by a TB Reach grant, the orga-
nization was created by Olivier Rusumba 
with the support of Emmanuel André 
with the aim of organizing the work 
of the screeners. Box 1 describes the 
organization in detail. Staff members 
from the organization and members of 
the national tuberculosis programme 
jointly provided a 3-day workshop for 
the volunteer screeners on the risk 
factors, symptoms and treatment of 
tuberculosis, as well as the importance 
of early detection. At the workshop, we 
held group discussions on strategies that 
could be implemented locally to target 
the people in the community thought 
to be at greatest risk due to particular 
living conditions or marginalization; 
we emphasized how people sharing 
homes with other tuberculosis patients 
were especially at risk. Through door-
to-door screening, volunteers identified 
such members of the community and 
referred them for testing if they reported 
a prolonged cough, by informing them 
of the location of local clinics perform-
ing free testing. Screeners compiled 
reports recording four key variables: 
(i) the number of people screened for 
the presence of a prolonged cough in 
their community; (ii) the number and 
proportion of people identified with a 
prolonged cough; (iii) the number and 
proportion of people with a prolonged 
cough who attended a clinic for testing; 
and (iv) individual test results regularly 
collected by the screeners at the local 
clinic. TB Reach and Challenge TB 
provided funding to cover administra-
tion costs and small incentive payments 
to volunteers.
Evaluation
Study objectives included quantifying 
the number of people within differ-
ent groups of high risk who needed to 
be screened to find one patient with 
sputum-smear-positive pulmonary 
tuberculosis, as well as determining the 
acceptability, effectiveness and impact 
of the active case-finding intervention 
and assessing its long-term sustain-
ability (Box 2).
We collected reports from screen-
ers detailing their activities, and cross-
checked these against each clinic’s 
official notification of the number and 
identity of patients diagnosed with 
sputum-smear-positive pulmonary tu-
berculosis. We calculated the total cost 
of the intervention, that is, direct activity 
expenses, including incentives paid to 
screeners and clinics, and operational 
and structural costs of Ambassadeurs de 
Lutte Contre la Tuberculose. We divided 
this cost by the number of people in the 
different groups, for example screeners, 
people screened, and people diagnosed 
with tuberculosis (Table 1). To assess 
sustainability we defined groups with 
Box 1. Non-profit organization created for tuberculosis active case-finding, Democratic 
Republic of the Congo, 2014–2016
People with tuberculosis and their communities in South Kivu created a non-profit organization 
called Ambassadeurs de Lutte Contre la Tuberculose.
Objectives:
To support members of tuberculosis-affected households by providing them with socially useful 
work actively seeking community members with a prolonged cough and referring them for 
tuberculosis testing. This aimed to reduce morbidity, mortality and contagion.
Organization:
Local volunteer groups of 1–20 screeners worked in the catchment area of their local clinic, to 
which they referred people with a prolonged cough. To create each group, we invited up to 10 
cured patients living in the clinic catchment area to participate in a 3-day workshop to learn 
from clinic staff about: tuberculosis disease; its transmission, treatment and under-detection; 
groups at high risk; and the need to actively identify and diagnose patients.
Screening:
Each volunteer group defined and organized their active case-finding activities, including how 
to target screening of people at high risk of tuberculosis. Screeners recorded whether those 
screened belonged to any of the high-risk groups: people residing in a household with a patient 
receiving tuberculosis treatment or in a prison, mining community or military base.
Financial incentives:
Each group received US$ 30 per quarter for administration and transport, and volunteer screeners 
received US$ 0.50 per symptomatic person who attended for tuberculosis testing. Payments 
were made after data validation in the quarterly notification report by clinic and provincial staff, 
subject to the availability of funds. The intervention also paid each clinic US$ 0.50 per diagnostic 
test performed, to remunerate the workload associated with increased patient referrals.
Funding:
The intervention was fully externally funded from the end of 2013 until the end of 2014; reduced 
external funding continued until the end of 2016.
US$: United States dollars.
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continuous activity as those reporting at 
least nine quarters of activity per year, 
without inactivity lasting longer than 
one quarter, and for which any single 
quarter of inactivity was separated by 
at least two quarters of activity.
Since two sputum-smear micros-
copy tests were the main tuberculosis 
testing in this setting, we only consid-
ered sputum-smear-positive pulmonary 
tuberculosis as bacteriologically con-
firmed tuberculosis.
To better capture the high diver-
sity of results reported between screen-
ing groups and the progress of each 
screening group over time, we analysed 
quarterly screening and tuberculosis 
notifications from health facilities as 
647 units, with an internal correlation 
for the successive results per clinic. 
These results had a negative-binomial 
gamma–Poisson distribution due to hy-
perdispersion between health facilities. 
This procedure, a requirement due to 
the structure of the data, gives a weight 
to each unit different from the crude 
count of the population, minimizing 
the influence of units with exceptionally 
high counts. Similarly, the relations be-
tween the reported screening activities, 
tuberculosis diagnoses and time were 
examined using a generalized linear re-
gression of a negative-binomial gamma–
Poisson variable. For percentages, we 
used a generalized linear regression of a 
β-binomial variable. We used quasi-least 
squares, which is suitable for calculating 
internal correlations to adjust the regres-
sion, and assumed a constant between-
year correlation matrix. Regression 
validity was checked by applying an 
Anscombe transform to residuals. We 
used the sandwich variance matrix to 
calculate statistical significance.
This study was an operational audit 
of programmatic and surveillance ano-
nymized data which were collected as 
part of the project, and did not require 
patient consent.
Results
In total, 1713 volunteers screened 
650 434 people, which resulted in 
4300 people diagnosed with sputum-
smear-positive pulmonary tuberculosis 
(Fig. 1). Fig. 2 and Fig. 3 show the 
crude numbers and proportions for 
effectiveness and impact of the active 
case-finding intervention, respectively. 
In the following sections we adjusted 
the proportions statistically to reduce 
the effect of very high counts.
Acceptability
All clinics and communities in the study 
area accepted the intervention (Fig. 1). 
On average, 69 groups (range, 24–100) 
of 775 screeners (range, 197–1713) par-
ticipated in the intervention each quar-
ter. Over the entire 3-year intervention, 
an average of 11% (73 418) of individuals 
screened reported a prolonged cough; 
69% (50 368) of those with a prolonged 
cough attended the clinic and were test-
ed for tuberculosis. We also calculated 
the average based on the results reported 
for each clinic and over each quarter. 
These percentages varied slightly com-
pared with the general figures due to the 
varying levels of intensity of screening 
between different areas and over time. 
Based on this second analytical ap-
proach, when each clinic operating over 
each quarter was considered a separate 
entity, 14% (95% confidence interval, 
CI: 13.34–14.66) of individuals screened 
reported a prolonged cough and 66% 
(95% CI: 64.33–67.67) of those with a 
prolonged cough attended the clinic for 
tuberculosis testing.
Effectiveness
On average, when each clinic over each 
quarter was considered as a separate 
entity, 10% (95% CI: 9.24–10.76) of 
Box 2. Objectives of tuberculosis active case-finding study, Democratic Republic of the 
Congo, 2014–2016
1. Acceptability of: the intervention to the community and health systems; participation in active 
case-finding to people who had received tuberculosis treatment; and attendance at a clinic to 
undergo testing to those screened who report a prolonged cough.
2. Effectiveness, assessed as: quantification of the number of people who needed to be screened 
to detect a single case of tuberculosis, including within marginalized populations at high risk 
of tuberculosis.
3. Impact, observed in: increasing tuberculosis case-finding in the clinics where the intervention 
took place; actively finding an important proportion of patients before ongoing passive case-
finding; and tangibly increasing provincial tuberculosis notification figures.
4. Sustainability, indicated by the ability of clinics to maintain the active-case finding intervention 
over time.
Table 1. Running costs of the active tuberculosis case-finding intervention, South Kivu, Democratic Republic of the Congo, 2014–2016











(n = 650 434)
Person with 
cough 
(n = 73 418)
Person 
tested 




Active screeners 24 44 594 58 646 0.07 0.61 0.89 10
Local health facilities 13 25 184 32 365 0.04 0.34 0.50 6
Field supervision 38 72 000 93 1043 0.11 0.98 1.43 17
Administration 25 46 800 60 678 0.07 0.64 0.93 11
TOTAL 100 188 578 243 2733 0.29 2.57 3.74 44
US$: United States dollars.
a  Defined as sputum-smear-positive pulmonary tuberculosis.
Note: These data do not take into account the costs associated with the initial training of the volunteer screeners and the implementation of screening groups, and 
inconsistencies arise in some totals due to rounding.
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patients who had tuberculosis testing 
were diagnosed with sputum-smear-
positive pulmonary tuberculosis. This 
proportion was similar (8.5%) when 
considering the entire intervention over 
the 3-year duration. Over the study 
period, the average yield of a screener 
was 1.8 new sputum-smear-positive 
pulmonary tuberculosis cases diagnosed 
per year. Members of marginalized 
groups contributed 19.7% (845/4300) 
of tuberculosis diagnoses (Fig. 2), 
although they only represented 5.1% 
(33 002/650 434) of people screened. 
When each clinic over each quarter 
was considered as a separate entity, the 
number who needed to be screened to 
detect a single case of tuberculosis was 
128 (95% CI: 113.9–142.1); this number 
was 151 when considering the entire in-
tervention as a whole. The number who 
needed to be screened was significantly 
(P < 0.0001) lower in mining camps 
(21), military camps (20) and prisons 
(69). By summing the costs associated 
with the implementation and training 
of the screening groups, the cost of the 
intervention per sputum-smear-positive 
pulmonary tuberculosis diagnosis was 
found to be US$ 44 (Table 1).
Impact
The presence of any screener(s) was 
associated with more sputum-smear-
positive pulmonary tuberculosis diag-
noses at the clinic level (P = 0.005; Fig. 3) 
and a greater number of screeners per 
group resulted in a greater number of 
diagnoses.
Throughout  2014–2016,  42% 
(4 300/10 247) of patients diagnosed 
in the South Kivu province were found 
through this active case-finding inter-
vention; annually, the intervention was 
associated with an increase in tuber-
culosis cases notified at the provincial 
level (P = 0.04). This increase is not 
statistically significant if adjusted for an 
estimated 3.1% annual increase in the 
provincial population, although reliable 
data were unavailable for changes in 
population size.
Sustainability
Sustainability was assessed over the 3 years 
of the intervention for the 24 groups who 
maintained continuous activity (Fig. 4 
and Fig. 5). These groups referred a higher 
proportion of people screened who were 
reporting a prolonged cough to clinics 
for tuberculosis testing compared with 
the 76 groups who reported interrupted 
























Fig. 2. Effectiveness of active tuberculosis case-finding, Democratic Republic of the 
Congo, 2014–2016 




























Screened (n) 617 432 33 002 17 693 480 10 876 3953
Positive 
diagnoses (n) 3455 845 135 7 508 195
People 
needed to 
screen (n) 179 39 131 69 21 20
% of positive 
diagnoses 0.56 2.56 0.76 1.46 4.67 4.93
Notes: The number of people needed to screen represents the number who needed to be screened to 
diagnose a single case of sputum-smear-positive pulmonary tuberculosis. The high-risk group contacts 
are defined as those living in a household with someone already diagnosed with tuberculosis.
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activity during the study (odds ratio: 1.3; 
95% CI: 1.3–1.4). While the 24 contin-
uous-activity groups represented 37% 
(634/1713) of screeners, they reported 
36% (234 156/650 434) of people screened, 
40% (29 367/73 418) of people reporting a 
prolonged cough, 47% (23 672/50 368) of 
those attending a clinic for tuberculosis 
testing and 59% (2537/4300) of sputum-
smear-positive pulmonary tuberculosis 
diagnoses during the intervention. Ac-
ceptability was higher among these 
continuous-activity groups compared 
with the average: the mean proportion of 
people reporting a prolonged cough who 
attended a clinic for tuberculosis testing 
(Fig. 4) was 77% (95% CI: 76.6–77.4) 
with an increase of 50% (95% CI: 33–67) 
observed between the first and the last 
quarter. When analysing the individual 
performance of screeners over the study 
period (Fig. 5), the number of diagnoses 
per screener per quarter increased by 
118% (95% CI: 70–166) between the first 
and the last quarter.
Discussion
This study highlights the utility of 
performing active case-finding in the 
populations underserved by the health 
system of the South Kivu province of 
the Democratic Republic of the Congo. 
Using volunteer screeners who had a 
personal or family history of tuberculo-
sis as active-case finders, organized as a 
local non-profit organization, probably 
explains the ability of the screeners to 
connect with members of high-risk 
groups and access remote populations. 
We also demonstrate the increasing ef-
fectiveness of these volunteer screeners 
over time. The low numbers of people 
who had to be screened to detect a 
single case of tuberculosis (only 20 in 
military camps), and the low costs per 
diagnosis (US$ 44), are compatible 
with WHO criteria5 for recommending 
active case-finding as a cost–effective, 
complementary approach to traditional 
case-finding. The observed number who 
needed to be screened to detect a single 
case of tuberculosis may have been even 
lower if more sensitive diagnostics, such 
as nucleic acid amplification test or 
culture had been available, if the clinical 
staff had been more consistent at diag-
nosing tuberculosis,21 or if chest radio-
graphs had been more widely available.
Levels of acceptability of the inter-
vention by communities, clinics, screen-
ers and those screened were all high. 
According to local screeners, potential 
reasons for not accepting a referral for 
tuberculosis testing may have included: 
(i) the considerable distance to clinics in 
rural areas; (ii) limited trust in the volun-
teer screeners; and (iii) the stigmatizing 
and impoverishing effects of tuberculosis.
The effectiveness of the present in-
tervention was comparable with active 
case-finding yield generally reported in 
populations with an annual incidence 
of tuberculosis cases greater than 300 
per 100 000 people.5 Our data show 
that the active case-finding interven-
tion mainly occurred in households 
and communities where tuberculosis 
was actively circulating (contacts in 
Fig. 2); the number of such individuals 
who needed to be screened to detect a 
single case of tuberculosis was 131. This 
number was even lower among people 
living in mining and military camps and 
prisons. This supports WHO policy5 that 
such groups should be prioritized for 
active case-finding.
The intervention potentially reduced 
tuberculosis-related morbidity and mor-
tality and reduced transmission of the 
disease in the community. The number 
of sputum-smear-positive pulmonary 
tuberculosis diagnoses increased with the 
number of screeners involved in each lo-
cal screening group. The intervention was 
also associated with increased provincial 
Fig. 3. Impact of active tuberculosis case-finding from 113 clinics, Democratic Republic 
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Note: The plot shows the mean and standard error of the mean. 
Fig. 4. Acceptability of active tuberculosis case-finding within the 24 continuous-
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Note: The plot shows the mean and standard error of the mean proportion of people screened with a 
prolonged cough who attended a clinic for testing.
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diagnoses, although this finding is un-
certain, because of limited demographic 
data; the pertinence of evaluating the 
intervention by provincial notification 
is, however, limited due to the fact that 
only a fraction of clinics participated. 
This non-randomized evaluation was 
highly informative, however, and should 
be complemented by future randomized 
studies.
The 24 screening groups that main-
tained continuous activity and received 
undisrupted funding throughout the 
evaluation demonstrated a higher perfor-
mance in terms of numbers of screeners, 
population screened, people identified 
with a prolonged cough, those tested 
for tuberculosis and positive diagnoses. 
Furthermore, in the continuous-activity 
groups, the number of people screened 
and tested and the number of new diagno-
ses all increased over time. These figures 
suggest that the ability of the volunteer 
screeners to perform active case-finding 
improves with experience, supporting 
longer-term projects. Through the very 
high number of contacts between the 
screeners and the population screened 
(representing approximately 10% of the 
population), the intervention probably 
increased awareness of tuberculosis and 
its symptoms in the general South Kivu 
population. However, sustainability is 
also influenced by the ability of the non-
profit organizations to secure funding; 
although we have demonstrated the 
effectiveness of this community-driven 
intervention, staff members are not 
skilled in responding to highly competi-
tive international grant calls and would 
benefit from international support to 
publicize their work.
Our study has three main limita-
tions intrinsically associated with the 
design of the intervention and the non-
profit characteristic of Ambassadeurs 
de Lutte Contre la Tuberculose: the high 
variability among the screening groups; 
the simplicity of the screening algo-
rithm; and a lack of data on the results 
of treatment following diagnosis. The 
high variability among the screening 
groups regarding the number of people 
screened and diagnosed with sputum-
smear-positive pulmonary tuberculosis 
could be explained by a variation in 
the baseline incidence of tuberculosis 
among different zones and the variability 
in the clinical skills of local medical staff, 
as has been suggested elsewhere.21 The 
screening protocol, the presence of a 
prolonged cough, was selected based on 
the fact that volunteers would have had 
little or no medical training. However, 
this symptom is only present in approxi-
mately 35% of patients with pulmonary 
tuberculosis disease. When followed by 
a positive smear microscopy or nucleic 
acid amplification test, only 21–32% of 
all people screened who actually have 
tuberculosis are diagnosed.4 Further, 
due to the nature of the clinical test, 
incidences of smear-negative pulmo-
nary tuberculosis or extra-pulmonary 
tuberculosis would have remained undi-
agnosed. Finally, we did not design this 
study to assess the outcome of patients 
undergoing treatment or to evaluate any 
differences in patient outcomes between 
those referred through active case-
finding compared with passive referral.
The challenges faced during this 
intervention were the reporting and 
supervision systems required to moni-
tor the activities of and provide support 
for screening groups facing problems. 
As detailed in Table 1, supervision 
represented 38% of the US$ 44 cost of 
each sputum-smear-positive pulmonary 
tuberculosis diagnosis; reaching screen-
ing groups who were scattered over the 
large province incurred travel costs for 
supervisors. The paper-based recording 
and dissemination of screening reports 
also represented a large proportion of 
the total cost (25%) of each diagnosis. 
Providing these groups with connected 
and digitalized reporting systems may 
decrease such costs in the future.
Our results suggest that if peer-led 
interventions can be funded long-term, 
that is, sustained, they can represent a 
valuable complement to the traditional 
and passive case-finding in the global ef-
fort to control tuberculosis. We propose 
that patients be encouraged to engage in 
active case-finding interventions at their 
local level; the observed improvement 
over time in the ability of such volunteer 
screeners among the most vulnerable, 
could help to reduce the costs associated 
with tuberculosis,22 while potentially 
contributing to its elimination. ■
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Fig. 5. Sustainability of active tuberculosis case-finding within the 24 continuous-



















































Year, quarters of continuous activity
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Note: The plot shows the mean and standard error of the mean number of sputum-smear-positive 
pulmonary tuberculosis diagnoses per screener per quarter.
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ملخص
اكتشاف حاالت السل النشط بني املرىض يف مجهورية الكونغو الديمقراطية
اكتشاف  بأفراد فحص متطوعني يف  تأثري االستعانة  اهلدف دراسة 
الكونغو  بجمهورية  كيفو،  جنوب  يف  النشطة  السل  حاالت 
مرتفع  خلطر  املعرضة  املجموعات  بني  وخاصة  الديمقراطية، 
لإلصابة بالسل.
يف  مرتفع  خلطر  املعرضة  املجموعات  عىل  التعرف  هبدف  الطريقة 
املجتمعات النائية وفحصها، قمنا بتدريب بأفراد فحص متطوعني، 
وخاصة أولئك الذين تلقوا العالج من مرض السل أو لدهيم تاريخ 
أفراد  للربح، وحصل  إنشاء منظمة غري هادفة  تم  للمرض.  عائيل 
اخلاصة  العدوى  انتقال  وكيفية  املرض  عىل  تدريب  عىل  الفحص 
به، يف حلقات عمل استمرت ملدة ثالثة أيام. سجل أفراد الفحص 
عدد األشخاص الذين تم فحصهم، والذين أفادوا بوجود سعال 
لفرتة ممتدة، وحرضوا للعيادة للخضوع للكشف، فضاًل عن نتائج 
الكشف. تم تقييم البيانات كل ثالثة أشهر خالل فرتة التدخل التي 
استمرت ملدة 3 سنوات )2014 إىل 2015(.
بفحص  املتطوعون  قام  عالية.  التدخل  مقبولية  كانت  النتائج 
650434 فردًا يف جمتمعاهتم املحلية، وأفاد 73418 منهم بوجود 
اختبار  إلجراء  للعيادة  الحقا  منهم   50368 أتى  طويل؛  سعال 
للكشف عن مرض السل. تم تشخيص اإلصابة بمرض السل يف 
151 شخصا تم فحصهم، بتكلفة قدرها 0.29 دوالر  1 من بني 
أمريكي لكل شخص تم فحصه، و 44 دوالرًا أمريكيًا للشخص 
أعضاء  أن  من  الرغم  عىل  باملرض.  إصابته  تشخيص  تم  الذي 
مستوى  من  يعانون  والذين  كبري،  خلطر  املعرضة  املجموعات 
 5.1٪ سوى  يمثلوا  مل  الصحية،  الرعاية  عىل  احلصول  من  أقل 
إال  فحصهم،  تم  الذين  األشخاص  من   )650434/33002(
تشخيصات  من   )4300/845(  19.7٪ بنسبة  سامهوا  قد  أهنم 
عدد  إىل  التدخل  أدى  فحصًا(.   39 لكل  واحد  )تشخيص  السل 
مسحة  بفحص  الرئوي  السل  بمرض  إضافيًا  تشخيصًا   4300
إمجايل  من   )10247/4300(  42٪ بنسبة  البصاق،  اختبار 
املقاطعات لتلك الفرتة.
املرىض عنرص  بني  النشط  السل  اكتشاف حاالت  يمثل  االستنتاج 
التقليدي عن احلاالت، وينبغي االستعانة به  تكمييل قّيم للكشف 












测试结果。在为期 3 年（2014-2016 年）的干预中，每
季度评估一次数据。
结 果 干 预 的 接 受 度 非 常 高。 志 愿 者 对 其 社 区
中 650434 人 进 行 筛 查， 其 中 73418 人 报 告 有 长 期
咳 嗽，50368 人 相 继 参 与 结 核 病 临 床 测 试。 在 筛
查人群中每 151 人中就有 1 人诊断为结核病，筛
查每人花费 0.29 美元 (US$)，诊断每人花费 44 美
元。尽管享受医疗服务机会较少的高风险群体仅占
所 有 被 筛 查 人 员 的 5.1% (33002/650434)， 他 们 却 占
确诊结核病患者（每 39 位筛查者中就有 1 人诊断）






Dépistage de la tuberculose active par les patients en République démocratique du Congo
Objectif Étudier les effets de l’utilisation d’examinateurs volontaires 
dans le dépistage de la tuberculose active au Sud-Kivu, en République 
démocratique du Congo, en particulier dans les groupes exposés à un 
risque élevé d’infection tuberculeuse.
Méthodes Afin d’identifier et d’examiner des groupes à haut risque 
dans des communautés isolées, nous avons formé des examinateurs 
volontaires, qui étaient principalement des individus ayant eux-mêmes 
reçu un traitement contre la tuberculose ou ayant un antécédent familial 
de la maladie. Une organisation à but non lucratif a été créée et les 
examinateurs ont reçu une formation sur la maladie et sa transmission dans 
le cadre d’ateliers de 3 jours. Les examinateurs ont enregistré le nombre 
de personnes examinées, faisant état d’une toux prolongée et qui se sont 
rendues dans un centre de consultation pour bénéficier d’un dépistage, 
ainsi que les résultats des examens. Les données ont été évaluées tous les 
trimestres pendant les 3 ans qu’a duré l’intervention (2014-2016).
Résultats L’acceptabilité de l’intervention était élevée. Les volontaires 
ont examiné 650 434 membres de leurs communautés, parmi lesquels 
73 418 ont fait état d’une toux prolongée; 50 368 se sont ensuite rendus 
dans un centre de consultation pour bénéficier d’un dépistage de 
la tuberculose. La tuberculose a été diagnostiquée chez 1 personne 
examinée sur 151, pour un coût de 0,29 dollar des États-Unis (US$) par 
personne examinée et 44 US$ par personne diagnostiquée. Bien que 
les membres des groupes à haut risque qui ont un accès plus restreint 
aux soins de santé ne représentaient que 5,1% (33 002/650 434) des 
personnes examinées, ils représentaient 19,7% (845/4300) des cas de 
tuberculose diagnostiqués (1 personne diagnostiquée sur 39 personnes 
examinées). L’intervention a donné lieu à 4300 autres diagnostics de la 
tuberculose pulmonaire à frottis positif, soit 42% (4300/10 247) du total 
de la province pour la période considérée.
Conclusion Le dépistage de la tuberculose active par les patients 
complète utilement le dépistage traditionnel et devrait être utilisé pour 
aider les systèmes de santé à éradiquer la tuberculose. 
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Резюме
Выявление случаев заболевания активным туберкулезом при активном участии самих пациентов в 
Демократической Республике Конго
Цель Изучить влияние использования добровольцев в качестве 
специалистов по скрининговому обследованию на степень 
выявления случаев заболевания активным туберкулезом в 
провинции Южное Киву, Демократической Республики Конго, 
особенно среди групп с высоким риском инфицирования 
туберкулезом.
Методы Чтобы выявить и отобрать группы с высоким риском 
инфицирования в отдаленных сообществах, авторы обучили 
специалистов-добровольцев проведению скринингового 
обследования (в основном тех, кто сам ранее получал лечение 
от туберкулеза или имел семейную историю заболевания). Была 
создана некоммерческая организация, которая организовала 
трехдневные семинары, где специалисты по скрининговому 
обследованию прошли курс, посвященный туберкулезу 
и способам передачи этой инфекции. Специалисты по 
скрининговому обследованию регистрировали количество 
людей, прошедших скрининг, лиц с продолжительным кашлем и 
тех, кто обратился в клинику для тестирования, а также результаты 
тестирования. Данные оценивались каждый квартал в течение 
трехлетнего периода вмешательства (2014–2016 гг.).
Результаты Приемлемость вмешательства была высокой. 
Волонтеры отобрали 650 434 человека в своих общинах, у 
73 418 из которых был отмечен продолжительный кашель; 
50 368 впоследствии обратились в клинику для тестирования на 
туберкулез. Туберкулез был диагностирован у 1 из 151 человека, 
прошедшего скрининговое обследование. Расходы на проведение 
скрининга составили 0,29 долл. США на человека, прошедшего 
скрининговое обследование, и 44 долл. США на человека, у 
которого туберкулез был подтвержден диагнозом. Несмотря 
на то что доля людей, входящих в группы повышенного риска 
с плохим доступом к медицинскому обслуживанию, составила 
лишь 5,1% (33 002/650 434) из тех, кто прошел скрининговое 
обследование, эта же доля людей составила 19,7% (845/4300) 
случаев подтвержденного диагнозом туберкулеза (1 диагноз на 
39 прошедших скрининговое обследование). Это вмешательство 
привело к дополнительным 4300 диагнозам туберкулеза легких 
с положительным результатом мазка мокроты, что составило 
42% (4300/10 247) от общего количества провинций за этот 
период.
Вывод Выявление случаев заболевания активным туберкулезом 
при активном участии самих пациентов представляет собой 
ценное дополнение к традиционному методу выявления случаев 
этого заболевания и должно использоваться для оказания 
помощи системам здравоохранения в борьбе с туберкулезом.
Resumen
Búsqueda de casos de tuberculosis activa dirigida por pacientes en la República Democrática del Congo 
Objetivo Investigar el efecto del uso de examinadores voluntarios para 
la detección de casos de tuberculosis activa en Kivu del Sur (República 
Democrática del Congo), sobre todo entre los grupos de alto riesgo de 
infección por tuberculosis.
Métodos Para identificar y examinar los grupos de alto riesgo en 
comunidades remotas, hemos formado a examinadores voluntarios, 
principalmente aquellos que habían recibido tratamiento para la 
tuberculosis o tenían antecedentes familiares de la enfermedad. Se 
creó una organización sin ánimo de lucro y los examinadores recibieron 
formación sobre la enfermedad y su transmisión en talleres de tres días. 
Los examinadores registraron el número de personas examinadas que 
mostraban una tos prolongada y que acudían a una clínica para hacerse 
la prueba, así como los resultados de la prueba. Los datos se evaluaron 
cada trimestre durante el periodo de tres años de la intervención 
(2014-2016).
Resultados La aceptación de la intervención fue elevada. Los 
voluntarios examinaron a 650 434 personas en sus comunidades, 73 418 
de las cuales presentaron una tos prolongada; posteriormente, 50 368 
acudieron a una clínica para someterse a pruebas de tuberculosis. Se 
diagnosticó tuberculosis a 1 de cada 151 personas examinadas, lo 
que costó 0,29 USD por persona examinada y 44 USD por persona 
diagnosticada. Aunque los miembros de los grupos de alto riesgo 
con peor acceso a la atención de la salud representaban solo el 5,1 % 
(33 002/650 434) de los examinados, supusieron el 19,7% (845/4300) 
de los diagnósticos de tuberculosis (1 diagnóstico por cada 39 
examinados). La intervención dio como resultado 4300 diagnósticos 
adicionales de tuberculosis pulmonar con frotis de esputo positivo, el 
42% (4300/10 247) del total provincial durante el periodo.
Conclusión La búsqueda de casos de tuberculosis activa dirigida por el 
paciente representa un complemento valioso a la búsqueda de casos 
tradicional y debería utilizarse para ayudar a los sistemas sanitarios a 
eliminar la tuberculosis.
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